Bharat Biotech ramps up Covaxin production capacity to 700 mn doses per annum April 20, 2021 Auto Bot News 0 The technology transfer process is well underway and IIL has the capabilities and expertise to manufacture inactivated viral vaccines at commercial scale and under biosafety containment, it added.